Alise Reicin is Chief Executive Officer of AVROBIO, Inc.. Currently has a direct ownership of 178,297 shares of AVRO, which is worth approximately $0. The most recent transaction as insider was on Dec 04, 2024, when has been sold 11,717 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 178K
7.03% 3M change
n/a 12M change
Total Value Held $0

ALISE REICIN Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 04 2024
BUY
Grant, award, or other acquisition
-
11,717 Added 6.17%
178,297 Common Stock
Jun 20 2024
BUY
Grant, award, or other acquisition
-
166,580 Added 50.0%
166,580 Common Stock

Also insider at

SANA
Sana Biotechnology, Inc. Healthcare
FIXX
Homology Medicines, Inc. Healthcare
AR

Alise Reicin

Chief Executive Officer
Seattle, WA

Track Institutional and Insider Activities on AVRO

Follow AVROBIO, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AVRO shares.

Notify only if

Insider Trading

Get notified when an Avrobio, Inc. insider buys or sells AVRO shares.

Notify only if

News

Receive news related to AVROBIO, Inc.

Track Activities on AVRO